195 related articles for article (PubMed ID: 27672055)
1. Is Pelvic Inflammatory Disease a Risk Factor for Ovarian Cancer?
Rasmussen CB; Jensen A; Albieri V; Andersen KK; Kjaer SK
Cancer Epidemiol Biomarkers Prev; 2017 Jan; 26(1):104-109. PubMed ID: 27672055
[TBL] [Abstract][Full Text] [Related]
2. Increased risk of borderline ovarian tumors in women with a history of pelvic inflammatory disease: A nationwide population-based cohort study.
Rasmussen CB; Jensen A; Albieri V; Andersen KK; Kjaer SK
Gynecol Oncol; 2016 Nov; 143(2):346-351. PubMed ID: 27549433
[TBL] [Abstract][Full Text] [Related]
3. Pelvic Inflammatory Disease and the Risk of Ovarian Cancer and Borderline Ovarian Tumors: A Pooled Analysis of 13 Case-Control Studies.
Rasmussen CB; Kjaer SK; Albieri V; Bandera EV; Doherty JA; Høgdall E; Webb PM; Jordan SJ; Rossing MA; Wicklund KG; Goodman MT; Modugno F; Moysich KB; Ness RB; Edwards RP; Schildkraut JM; Berchuck A; Olson SH; Kiemeney LA; Massuger LF; Narod SA; Phelan CM; Anton-Culver H; Ziogas A; Wu AH; Pearce CL; Risch HA; Jensen A;
Am J Epidemiol; 2017 Jan; 185(1):8-20. PubMed ID: 27941069
[TBL] [Abstract][Full Text] [Related]
4. Risk of ovarian cancer in women with pelvic inflammatory disease: a population-based study.
Lin HW; Tu YY; Lin SY; Su WJ; Lin WL; Lin WZ; Wu SC; Lai YL
Lancet Oncol; 2011 Sep; 12(9):900-4. PubMed ID: 21835693
[TBL] [Abstract][Full Text] [Related]
5. Association of pelvic inflammatory disease (PID) with ovarian cancer: a nationwide population-based retrospective cohort study from Taiwan.
Chang CY; Lin KY; Huang CC; Lin WC
BMC Womens Health; 2021 Jul; 21(1):274. PubMed ID: 34320962
[TBL] [Abstract][Full Text] [Related]
6. Pelvic inflammatory disease and risk of epithelial ovarian cancer: a national population-based case-control study in Sweden.
Jonsson S; Jonsson H; Lundin E; Häggström C; Idahl A
Am J Obstet Gynecol; 2024 Jan; 230(1):75.e1-75.e15. PubMed ID: 37778677
[TBL] [Abstract][Full Text] [Related]
7. Association between pelvic inflammatory disease and risk of ovarian cancer: An updated meta-analysis.
Piao J; Lee EJ; Lee M
Gynecol Oncol; 2020 May; 157(2):542-548. PubMed ID: 32037193
[TBL] [Abstract][Full Text] [Related]
8. Pelvic inflammatory disease and risk of invasive ovarian cancer and ovarian borderline tumors.
Rasmussen CB; Faber MT; Jensen A; Høgdall E; Høgdall C; Blaakær J; Kjaer SK
Cancer Causes Control; 2013 Jul; 24(7):1459-64. PubMed ID: 23615817
[TBL] [Abstract][Full Text] [Related]
9. Tubal ligation and salpingectomy and the risk of epithelial ovarian cancer and borderline ovarian tumors: a nationwide case-control study.
Madsen C; Baandrup L; Dehlendorff C; Kjaer SK
Acta Obstet Gynecol Scand; 2015 Jan; 94(1):86-94. PubMed ID: 25256594
[TBL] [Abstract][Full Text] [Related]
10. Risk of uterine, ovarian and breast cancer following pelvic inflammatory disease: a nationwide population-based retrospective cohort study.
Shen CC; Hu LY; Yang AC; Chiang YY; Hung JH; Tsai SJ
BMC Cancer; 2016 Nov; 16(1):839. PubMed ID: 27809870
[TBL] [Abstract][Full Text] [Related]
11. Birth weight and the risk of histological subtypes of ovarian and endometrial cancers: Results from the Copenhagen School Health Records Register.
Trabert B; Aarestrup J; Ulrich LG; Wentzensen N; Sørensen TIA; Baker JL
Gynecol Oncol; 2018 Mar; 148(3):547-552. PubMed ID: 29331371
[TBL] [Abstract][Full Text] [Related]
12. Drugs with potential chemopreventive properties in relation to epithelial ovarian cancer--a nationwide case-control study.
Baandrup L
Dan Med J; 2015 Jul; 62(7):. PubMed ID: 26183052
[TBL] [Abstract][Full Text] [Related]
13. Pelvic inflammation and the pathogenesis of ovarian cancer: a cohort study.
McAlpine JN; Lisonkova S; Joseph KS; McComb PF
Int J Gynecol Cancer; 2014 Oct; 24(8):1406-13. PubMed ID: 25191876
[TBL] [Abstract][Full Text] [Related]
14. Depression and risk of epithelial ovarian cancer: Results from two large prospective cohort studies.
Huang T; Poole EM; Okereke OI; Kubzansky LD; Eliassen AH; Sood AK; Wang M; Tworoger SS
Gynecol Oncol; 2015 Dec; 139(3):481-6. PubMed ID: 26449316
[TBL] [Abstract][Full Text] [Related]
15. Risk factors for epithelial ovarian cancer in Japan - results from the Japan Public Health Center-based Prospective Study cohort.
Weiderpass E; Sandin S; Inoue M; Shimazu T; Iwasaki M; Sasazuki S; Sawada N; Yamaji T; Tsugane S
Int J Oncol; 2012 Jan; 40(1):21-30. PubMed ID: 21904774
[TBL] [Abstract][Full Text] [Related]
16. Type II diabetes mellitus and the incidence of epithelial ovarian cancer in the cancer prevention study-II nutrition cohort.
Gapstur SM; Patel AV; Diver WR; Hildebrand JS; Gaudet MM; Jacobs EJ; Campbell PT
Cancer Epidemiol Biomarkers Prev; 2012 Nov; 21(11):2000-5. PubMed ID: 22941335
[TBL] [Abstract][Full Text] [Related]
17. Association between pelvic inflammatory disease, infertility, ectopic pregnancy and the development of ovarian serous borderline tumor, mucinous borderline tumor and low-grade serous carcinoma.
Stewart LM; Stewart CJR; Spilsbury K; Cohen PA; Jordan S
Gynecol Oncol; 2020 Mar; 156(3):611-615. PubMed ID: 31983516
[TBL] [Abstract][Full Text] [Related]
18. Pelvic inflammatory disease and the risk of epithelial ovarian cancer.
Risch HA; Howe GR
Cancer Epidemiol Biomarkers Prev; 1995; 4(5):447-51. PubMed ID: 7549798
[TBL] [Abstract][Full Text] [Related]
19. Parity and Oral Contraceptive Use in Relation to Ovarian Cancer Risk in Older Women.
McGuire V; Hartge P; Liao LM; Sinha R; Bernstein L; Canchola AJ; Anderson GL; Stefanick ML; Whittemore AS
Cancer Epidemiol Biomarkers Prev; 2016 Jul; 25(7):1059-63. PubMed ID: 27197274
[TBL] [Abstract][Full Text] [Related]
20. Association between pelvic inflammatory disease and subsequent salpingectomy on the risk for ovarian cancer.
Falconer H; Yin L; Salehi S; Altman D
Eur J Cancer; 2021 Mar; 145():38-43. PubMed ID: 33418235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
